Clinical Trials Browser

Uveal Melanoma × Vorinostat × 90 days × Clear all

NCT01587352 2026-04-13

Vorinostat in Treating Patients With Metastatic Melanoma of the Eye

Phase 2 Active not recruiting

Uveal Melanoma